WilliamWoodMD

PubMed

• 58 citations
  Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
  Kathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, S...> ;Journal of the National Cancer Institute. 2021 Apr 6
• 94 citations
  Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analys...
  Joseph A. Sparano, Robert Gray, DF Makower, Kathy S. Albain, Thomas James Saphner, Sunil Badve, Lynne I. Wagner, Virginia G. Kaklamani, Maccon M. Keane, Henry L. Gomez...> ;JAMA Oncology. 2020 Mar 1
• 3 citations
  Breast Reconstruction in the Setting of Postmastectomy Radiotherapy: Controversies and Disparities.
  Tran B Ho, William C. Wood, Preeti D Subhedar Mspt> ;Oncology. 2019 Dec 13
• 284 citations
  Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
  Joseph A. Sparano, Robert Gray, Peter M. Ravdin, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Ma...> ;The New England Journal of Medicine. 2019 Jun 3
• 3 citations
  Multidisciplinary Approaches to Chest Wall Recurrences of Breast Cancer.
  Cletus Arciero, Peter Thompson, Jane L. Meisel, Caitlin E. Taylor, Mylin A. Torres, William C. Wood> ;Oncology. 2018 Aug 15
• 11 citations
  Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth?
  Aileen C. Johnson, Cecilia G. Ethun, Yuan Liu, Alexandra G. Lopez-Aguiar, Thuy B. Tran, George A. Poultsides, Valerie P. Grignol, J. Harrison Howard, Meena Bedi, T. Cl...> ;Journal of the American College of Surgeons. 2018 Sep 1
• 1251 citations
  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
  Joseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, J...> ;The New England Journal of Medicine. 2018 Jun 3
• 41 citations
  Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort s...
  Eileen Rakovitch, Robert Gray, Frederick L. Baehner, Rinku Sutradhar, Michael Crager, S. Gu, Sharon Nofech-Mozes, Sunil Badve, Wedad Hanna, L. L. Hughes, William C. Wo...> ;Breast Cancer Research and Treatment. 2018 Jan 31
• 576 citations
  Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
  Bernard Asselain, William E. Barlow, John M. S. Bartlett, Jonas Bergh, Elizabeth Bergsten-Nordström, Judith M Bliss, Francesco Boccardo, Clare Boddington, Jan Bogaerts...> ;The Lancet. Oncology. 2018 Jan 1
• Counterpoint: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice? RT Should Not Be Standard Practice After Surgery for DCIS.
  William C. Wood> ;Oncology. 2017 Aug 15
• 13 citations
  Genomic deletion of GIT2 induces a premature age-related thymic dysfunction and systemic immune system disruption
  Sana Siddiqui, Ana Lustig, Arnell Carter, Mathavi Sankar, Caitlin M. Daimon, Richard T. Premont, Harmonie Etienne, Jaana van Gastel, Abdelkrim Azmi, Jonathan Janssens,...> ;Aging. 2017 Mar 4
• 3 citations
  Ductal Carcinoma In Situ of the Breast: Should Breast Irradiation Be Routinely Added to Surgical Excision?
  William C. Wood> ;Journal of Oncology Practice. 2016 Sep 21
• 393 citations
  Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer
  Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele, Christina Yau, Laura J. van't Veer, Meredith Buxton, Michael Hogarth, Nola M. Hylton, Melissa Paoloni, Jane Pe...> ;The New England Journal of Medicine. 2016 Jul 6
• Reply to C. Shah et al
  Lawrence J. Solin, Robert Gray, Lorie L. Hughes, William C. Wood, Mary Ann Lowen, Sunil Badve, Frederick L. Baehner, James N. Ingle, Edith A. Perez, Abram Recht, Josep...> ;Journal of Clinical Oncology. 2016 May 20
• Real Personalized Medicine
  James O. Armitage, William C. Wood, Dan L. Longo> ;Journal of the National Comprehensive Cancer Network. 2016 Feb 1
• 183 citations
  Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study
  Lawrence J. Solin, Robert Gray, Lorie L. Hughes, William C. Wood, Mary Ann Lowen, Sunil Badve, Frederick L. Baehner, James N. Ingle, Edith A. Perez, Abram Recht, Josep...> ;Journal of Clinical Oncology. 2015 Nov 20
• 938 citations
  Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
  Joseph A. Sparano, Robert Gray, D. F. Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, E. A. Perez, John A. O...> ;The New England Journal of Medicine. 2015 Nov 18
• 450 citations
  Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
  Joop P. W. van den Bergh, Kathleen I. Pritchard, KS Albain, Stewart J. Anderson, Rodrigo Arriagada, William E. Barlow, W. Bergsten-Nordström, Judith M Bliss, Francesco...> ;Lancet. 2015 Oct 3
• 127 citations
  Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer
  Joseph A. Sparano, Fengmin Zhao, Silvana Martino, Jennifer A. Ligibel, Edith A. Perez, Tom Saphner, Antonio C. Wolff, George W. Sledge, William C. Wood, Nancy E. Davidson> ;Journal of Clinical Oncology. 2015 Jun 15
• 87 citations
  Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor–Positive Breast Cancer...
  Amye J. Tevaarwerk, Molin Wang, Fengmin Zhao, John H. Fetting, David Cella, Lynne I. Wagner, Silvana Martino, James N. Ingle, Joseph A. Sparano, Lawrence J. Solin, Wil...> ;Journal of Clinical Oncology. 2014 Oct 27
• 957 citations
  Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
  Sylvia Adams, Robert Gray, Sandra Demaria, Lori J. Goldstein, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Molin Wang, Vicky Jones, Thomas J. Saphner, Antonio...> ;Journal of Clinical Oncology. 2014 Sep 20
• 5 citations
  The Current Clinical Value of the DCIS Score
  William C. Wood, Michael Alvarado, Daniel J. Buchholz, David Hyams, Shelley Hwang, Jennifer Manders, Catherine C. Park, Lawrence J. Solin, Julia White, Shawna Willey> ;Oncology. 2014 May 15
• 1 citations
  Reply to P.G. Tsoutsou et al, O. Kaidar-Person et al, and A. Courdi et al
  Kevin S. Hughes, Lauren Schnaper, Jennifer R. Bellon, Constance Cirrincione, Donald A. Berry, Beryl McCormick, Hyman B. Muss, Barbara L. Smith, Clifford A. Hudis, Eric...> ;Journal of Clinical Oncology. 2013 Nov 4
• 30 citations
  A pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration
  John W. Kitchens, Nawal Kassem, William C. Wood, Thomas W Stone, Rick D. Isernhagen, Edward H. Wood, Bradley A. Hancock, Milan Radovich, Josh Waymire, Lang Li, Bryan P...> ;Clinical Ophthalmology. 2013 Oct 10
• 20 citations
  Close/positive margins after breast-conserving therapy: Additional resection or no resection?
  William C. Wood> ;Breast. 2013 Aug 1
• Join now to see all